Phosphorylation by p38 MAPK as an Alternative Pathway for GSK3β Inactivation
Top Cited Papers
- 2 May 2008
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 320 (5876) , 667-670
- https://doi.org/10.1126/science.1156037
Abstract
Glycogen synthase kinase 3β (GSK3β) is involved in metabolism, neurodegeneration, and cancer. Inhibition of GSK3β activity is the primary mechanism that regulates this widely expressed active kinase. Although the protein kinase Akt inhibits GSK3β by phosphorylation at the N terminus, preventing Akt-mediated phosphorylation does not affect the cell-survival pathway activated through the GSK3β substrate β-catenin. Here, we show that p38 mitogen-activated protein kinase (MAPK) also inactivates GSK3β by direct phosphorylation at its C terminus, and this inactivation can lead to an accumulation of β-catenin. p38 MAPK–mediated phosphorylation of GSK3β occurs primarily in the brain and thymocytes. Activation of β-catenin–mediated signaling through GSK3β inhibition provides a potential mechanism for p38 MAPK–mediated survival in specific tissues.Keywords
This publication has 24 references indexed in Scilit:
- p53-Deficient Cells Rely on ATM- and ATR-Mediated Checkpoint Signaling through the p38MAPK/MK2 Pathway for Survival after DNA DamageCancer Cell, 2007
- p38 MAP kinase plays a role in G2 checkpoint activation and inhibits apoptosis of human B cell lymphoma cells treated with etoposideApoptosis, 2005
- Erk Associates with and Primes GSK-3β for Its Inactivation Resulting in Upregulation of β-CateninMolecular Cell, 2005
- Activation and signaling of the p38 MAP kinase pathwayCell Research, 2005
- The p38-Mediated Stress-Activated Checkpoint: A Rapid Response System for Delaying Progression through Antephase and Entry into MitosisCell Cycle, 2004
- Mechanism of p38 MAP kinase activation in vivoGenes & Development, 2003
- Wnt-3A/β-Catenin Signaling Induces Transcription from the LEF-1 PromoterJournal of Biological Chemistry, 2002
- The proto-oncogene c-myc in hematopoietic development and leukemogenesisOncogene, 2002
- GSK3 takes centre stage more than 20 years after its discoveryBiochemical Journal, 2001
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995